 |
 |
 |
November 3rd:
FDA Accepts Arana's Anti-inflammatory IND

September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer

September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins
 more news >




Feb, 2008:
BIO CEO & Investor Conference
 more events >
|
 |